News Conference News TCT 2020 Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate Shelley Wood October 14, 2020
News Conference News TCT 2020 Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19 Todd Neale October 14, 2020
News Conference News EAS 2020 Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank Michael O'Riordan October 07, 2020
News Daily News Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors Shelley Wood September 30, 2020
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News PCI Volumes Rise in US and Japan, but for Different Reasons Michael O'Riordan September 14, 2020
News Conference News ESC 2020 Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC Shelley Wood August 31, 2020
News Conference News ESC 2020 Updated ESC A-fib Guidance Proposes New Path for Diagnosis, Classification, and Care Shelley Wood August 30, 2020
News Conference News ESC 2020 More Than Half of Patients See a GP in the 2 Weeks Before OHCA Yael L. Maxwell August 28, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2020 Caitlin E. Cox August 28, 2020
News Daily News US Mortality Rates for CVD Have Stalled as Racial Disparities Widen Yael L. Maxwell August 19, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI L.A. McKeown August 10, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Premature CV Death Is Not Declining Fast Enough: National Data L.A. McKeown July 31, 2020